Mutated fukutin-related protein (FKRP) localises as wild type in differentiated muscle cells

N F Dolatshad1, M Brockington, S Torelli

  • 1Dubowitz Neuromuscular Unit, Department of Paediatrics, Hammersmith Hospital, Imperial College, Du Cane Road, London W12 ONN, UK.

Insights

Mutations in the Fukutin-related protein (FKRP) gene cause muscular dystrophy. This study found FKRP mislocalization is not the primary disease mechanism, suggesting Golgi dysfunction instead.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in the Fukutin-related protein (FKRP) gene are linked to congenital and limb girdle muscular dystrophies.
  • Previous hypotheses suggested FKRP mislocalization from the Golgi apparatus as the primary disease mechanism.

Purpose of the Study:

  • To investigate the cellular localization of wild-type (WT) and mutant FKRP constructs.
  • To determine if FKRP mislocalization from the Golgi is the main mechanism driving FKRP-associated muscular dystrophies.

Main Methods:

  • Transfection of V5-tagged FKRP expression constructs (WT, P448L, C318Y, L276I) into differentiated C2C12 myotubes and mouse tibialis anterior muscle.
  • Localization studies using GM130 as a Golgi marker in transfected myotubes and Cos-7 cells.
  • Immunolabeling of FKRP in muscle biopsies from MDC1C and LGMD2I patients.

Main Results:

  • WT and L276I FKRP localized to the Golgi in Cos-7 cells, while P448L and C318Y mutants were mislocalized in undifferentiated cells.
  • In differentiated C2C12 myotubes and mouse muscle, all FKRP constructs (WT and mutants) showed clear co-localization with the Golgi marker.
  • FKRP immunolabeling in MDC1C and LGMD2I patient muscle was similar to normal controls.

Conclusions:

  • FKRP retention in the endoplasmic reticulum is unlikely to be the primary disease mechanism in FKRP-associated muscular dystrophies.
  • Disease pathogenesis may involve disruption of FKRP's functional activity or substrate interactions within the Golgi apparatus.